GeoVax Shareholders Approve Reverse Stock Split at Special Meeting

• GeoVax Labs shareholders approved a reverse stock split at a special meeting on October 27, 2026.
• The approved split ratio ranges from 1-for-10 to 1-for-25, with the board to determine the final ratio.
• Shareholders also authorized issuance of up to 11,395,256 common shares upon exercise of common stock purchase warrants issued to an institutional investor.
• The warrants were issued in connection with a warrant exercise inducement that occurred on August 25, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GeoVax Labs Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-033610), on October 27, 2026, and is solely responsible for the information contained therein.